相关实验视频

Updated: Jun 26, 2025

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

11.9K

总和H特异性生长/分化因子15水平不受利拉格卢提德或纳尔特雷/布罗的使用影响

Sofia K Konstantinidou1, Georgia Argyrakopoulou2, Stamatia Simati1

  • 1First Department of Propaedeutic Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece.

Diabetes, obesity & metabolism
|May 17, 2024
PubMed
概括

抗肥胖药物利拉古 (Lira) 和纳尔特雷/布罗 (N/B) 并没有改变生长/分化因子15 (GDF-15) 的水平. 这项研究发现,在治疗期间,超重或肥胖个体的总或H特定GDF-15没有显著变化.

关键词:
在GDF-1515中.在GFRAL中,GFRAL是GFRAL的一部分.在 GLP1 中,GLP1 是 GLP1 的代名词.作为GLP-1受体激活剂.利拉格卢提德 (liraglutide) 是一种葡萄糖类药物.纳尔特雷克松 - 布普罗皮翁肥胖 肥胖 肥胖 肥胖 肥胖 肥胖 肥胖 肥胖

更多相关视频

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies06:27

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

727
Functional Interrogation of Adult Hypothalamic Neurogenesis with Focal Radiological Inhibition11:45

Functional Interrogation of Adult Hypothalamic Neurogenesis with Focal Radiological Inhibition

Published on: November 14, 2013

12.2K

相关概念视频

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
318